Elite Pharmaceuticals's total assets for Q2 2026 were $117.25M, a decrease of ― from the previous quarter. ELTP total liabilities were $44.99M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.